岡崎慶斗

オカザキケイト | Okazaki Keito

所属機関・部署：
職名：助教
競争的資金等の研究課題 (3件)：

論文 (10件)：

Makiko Hayashi, Keito Okazaki, Thales Papgiannakopoulos, Hozumi Motohashi. The Complex Roles of Redox and Antioxidant Biology in Cancer. Cold Spring Harbor Perspectives in Medicine. 2024. a041546-a041546
Kazuki Hayasaka, Shinya Ohkouchi, Ryoko Saito-Koyama, Yamato Suzuki, Keito Okazaki, Hiroki Sekine, Tatsuaki Watanabe, Hozumi Motohashi, Yoshinori Okada. Aging Exacerbates Murine Lung Ischemia-Reperfusion Injury by Excessive Inflammation and Impaired Tissue Repair Response. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2023
Shohei Murakami, Yusuke Kusano, Keito Okazaki, Takaaki Akaike, Hozumi Motohashi. NRF2 signalling in cytoprotection and metabolism. British journal of pharmacology. 2023
Keito Okazaki, Hayato Anzawa, Fumiki Katsuoka, Kengo Kinoshita, Hiroki Sekine, Hozumi Motohashi. CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells. The Journal of Biochemistry. 2022. 171. 5. 567-578
Keito Okazaki, Hayato Anzawa, Zun Liu, Nao Ota, Hiroshi Kitamura, Yoshiaki Onodera, Md Morshedul Alam, Daisuke Matsumaru, Takuma Suzuki, Fumiki Katsuoka, et al. Publisher Correction: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers. Nature communications. 2021. 12. 1. 506-506

書籍 (1件)：

講演・口頭発表等 (4件)：

NRF2活性化非小細胞肺がんにおけるRNA分解酵素Rengase-1の役割
(第96回日本生化学会大会 2023)
NRF2活性化がんにおけるRNA分解酵素Regnase-1の役割.
(第81回日本癌学会学術総会 2022)
NRF2活性化状態におけるCEBPB依存的な転写制御とその意義
(第80回日本癌学会学術総会 2021)
Enhancer Remodeling at the NOTCH3 Locus Licenses NRF2 for the Promotion of a Stem-like Phenotype in Lung Cancers.
(Environmental Response V/17th JBS Biofrontier Symposium 2019)

学位 (1件)：

受賞 (5件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

岡崎 慶斗